Date published: 2025-11-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

1700112E06Rik Inhibitors

1700112E06Rik Inhibitors encompass a range of compounds identified to modulate the activity of the protein expressed by the gene 1700112E06Rik. This protein, like many in cellular biology, plays a role in a multitude of intracellular processes. The inhibitors targeting this protein are characterized by their ability to interact specifically with its functional domains, thereby altering its activity. This interaction can occur through various mechanisms, including but not limited to competitive inhibition, where the inhibitor molecules bind to the active site of the protein, allosteric inhibition, where binding occurs at a site other than the active site leading to a change in the protein's conformation and activity, and irreversible inhibition, where the inhibitor forms a covalent bond with the protein, permanently affecting its function. The development of these inhibitors is rooted in an understanding of the protein's structure and functional mechanisms.

The process of identifying and characterizing 1700112E06Rik Inhibitors typically involves a combination of computational and experimental approaches. Initially, computational methods such as molecular docking and dynamic simulation are employed to predict the interaction between potential inhibitors and the target protein. These in silico studies are invaluable in identifying promising compounds by analyzing how well they fit into the active or allosteric sites of the protein and predicting the potential effects of these interactions on the protein's function. Following this, experimental validation is crucial. This involves synthesizing the predicted inhibitors and assessing their efficacy and specificity through a series of biochemical assays. These assays may include enzyme activity measurements, binding affinity studies using techniques like surface plasmon resonance or isothermal titration calorimetry, and cell-based assays to observe the physiological effects of inhibition. Such rigorous testing ensures that the identified compounds indeed modulate the activity of 1700112E06Rik in the desired manner. The ultimate goal in the study and development of these inhibitors is to gain a deeper understanding of the protein's role in cellular processes and how modulating its activity affects these processes.

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$62.00
$155.00
$320.00
233
(4)

Inhibits mTOR, a key regulator of cell growth and proliferation.

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$66.00
$219.00
$417.00
97
(3)

A PI3K inhibitor, affecting cell growth and survival signaling pathways.

Staurosporine

62996-74-1sc-3510
sc-3510A
sc-3510B
100 µg
1 mg
5 mg
$82.00
$150.00
$388.00
113
(4)

A potent, broad-spectrum inhibitor of protein kinases.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$121.00
$392.00
148
(1)

A PI3K inhibitor, impacting various signaling pathways.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$88.00
$342.00
284
(5)

Specifically inhibits p38 MAP kinase, involved in stress responses.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$39.00
$90.00
212
(2)

An inhibitor of MEK, which acts upstream of ERK in the MAPK pathway.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

Inhibits JNK, influencing apoptosis and cellular differentiation.

5-Azacytidine

320-67-2sc-221003
500 mg
$280.00
4
(1)

Acts on DNA methylation, affecting gene expression.

Trichostatin A

58880-19-6sc-3511
sc-3511A
sc-3511B
sc-3511C
sc-3511D
1 mg
5 mg
10 mg
25 mg
50 mg
$149.00
$470.00
$620.00
$1199.00
$2090.00
33
(3)

A histone deacetylase inhibitor, affecting chromatin and gene expression.

Cyclopamine

4449-51-8sc-200929
sc-200929A
1 mg
5 mg
$92.00
$204.00
19
(1)

Inhibits the Hedgehog signaling pathway.